Selectins impair regulatory T cell function and contribute to systemic lupus erythematosus pathogenesis.


Journal

Science translational medicine
ISSN: 1946-6242
Titre abrégé: Sci Transl Med
Pays: United States
ID NLM: 101505086

Informations de publication

Date de publication:
30 06 2021
Historique:
received: 08 01 2020
revised: 14 03 2021
accepted: 25 05 2021
entrez: 1 7 2021
pubmed: 2 7 2021
medline: 13 7 2021
Statut: ppublish

Résumé

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a loss of tolerance toward self-nucleic acids, autoantibody production, interferon expression and signaling, and a defect in the regulatory T (T

Identifiants

pubmed: 34193612
pii: 13/600/eabi4994
doi: 10.1126/scitranslmed.abi4994
pii:
doi:

Substances chimiques

Selectins 0
Transforming Growth Factor beta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn
Type : ErratumIn

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Auteurs

Marc Scherlinger (M)

Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.
Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.
UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.

Vivien Guillotin (V)

Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.
UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Department of Internal Medicine, Saint André, Bordeaux University Hospital, 33076 Bordeaux, France.

Isabelle Douchet (I)

UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.

Pierre Vacher (P)

INSERM U1218, 33076 Bordeaux, France.

Andréa Boizard-Moracchini (A)

UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.

Jean-Philippe Guegan (JP)

Explicyte, 229 Cours de l'Argonne, 33000 Bordeaux, France.

Anne Garreau (A)

UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.

Nathalie Merillon (N)

UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.

Agathe Vermorel (A)

Nephrology Department, Bordeaux University Hospital, 33076 Bordeaux, France.

Emmanuel Ribeiro (E)

Department of Internal Medicine, Saint André, Bordeaux University Hospital, 33076 Bordeaux, France.

Irène Machelart (I)

Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.
Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France.

Estibaliz Lazaro (E)

Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.
Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France.

Lionel Couzi (L)

Nephrology Department, Bordeaux University Hospital, 33076 Bordeaux, France.

Pierre Duffau (P)

Department of Internal Medicine, Saint André, Bordeaux University Hospital, 33076 Bordeaux, France.

Thomas Barnetche (T)

Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.
Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.

Jean-Luc Pellegrin (JL)

Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.
Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France.

Jean-François Viallard (JF)

Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.
Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, 33604, Pessac, France.

Maya Saleh (M)

UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.

Thierry Schaeverbeke (T)

Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.
Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.

Patrick Legembre (P)

Contrôle de la Réponse Immune B et lymphoproliférations, CRIBL, UMR CNRS 7276, INSERM 1262, Limoges, France.

Marie-Elise Truchetet (ME)

Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France.
Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.
UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.

Hélène Dumortier (H)

CNRS, UPR 3572 I2CT, IBMC, 67000 Strasbourg, France.

Cécile Contin-Bordes (C)

UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Department of Immunology and Immunogenetics, Bordeaux University Hospital, 33076 Bordeaux, France.

Vanja Sisirak (V)

UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.

Christophe Richez (C)

Department of Rheumatology, Pellegrin, Bordeaux University Hospital, 33076 Bordeaux, France. patrick.blanco@chu-bordeaux.fr christophe.richez@chu-bordeaux.fr.
Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France.
UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.

Patrick Blanco (P)

Centre national de référence maladie auto-immune et systémique rares Est/Sud-Ouest (RESO), Bordeaux University Hospital, 33076 Bordeaux, France. patrick.blanco@chu-bordeaux.fr christophe.richez@chu-bordeaux.fr.
UMR-CNRS 5164, ImmunoConcept, University of Bordeaux, 33076 Bordeaux, France.
Department of Immunology and Immunogenetics, Bordeaux University Hospital, 33076 Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH